Changing the Cancer Diagnosis: The Case of Follicular Variant of Papillary Thyroid Cancer-Primum Non Nocere and NIFTP.

[1]  A. Tischler,et al.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. , 2016, JAMA oncology.

[2]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[3]  J. Barletta,et al.  Absence of BRAF V600E in non‐infiltrative, non‐invasive follicular variant of papillary thyroid carcinoma , 2015, Histopathology.

[4]  I. Ganly,et al.  Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. , 2015, Human pathology.

[5]  A. Miyauchi,et al.  Nonoperative management of low-risk differentiated thyroid carcinoma , 2014, Current opinion in oncology.

[6]  Hyeong Sik Ahn,et al.  Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. , 2014, The New England journal of medicine.

[7]  G. Penna,et al.  Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm? , 2014, Clinical endocrinology.

[8]  Sudhir Srivastava,et al.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change. , 2014, The Lancet. Oncology.

[9]  J. Lubin,et al.  The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. , 2014, The Journal of clinical endocrinology and metabolism.

[10]  Mba Adam Hauch MD,et al.  Total Thyroidectomy is Associated with Increased Risk of Complications for Low- and High-Volume Surgeons , 2014, Annals of Surgical Oncology.

[11]  P. Newcomb,et al.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. , 2013, Health affairs.

[12]  S. Kraft,et al.  Risk stratification of follicular variant of papillary thyroid carcinoma. , 2013, Thyroid : official journal of the American Thyroid Association.

[13]  I. Ganly,et al.  Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy , 2011, Cancer.

[14]  Zhiyan Liu,et al.  Encapsulated follicular thyroid tumor with equivocal nuclear changes, so‐called well‐differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal , 2011, Cancer science.

[15]  S. Piana,et al.  Encapsulated Well-differentiated Follicular-patterned Thyroid Carcinomas Do Not Play a Significant Role in the Fatality Rates From Thyroid Carcinoma , 2010, The American journal of surgical pathology.

[16]  M. Santoro,et al.  Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. , 2007, The Journal of clinical endocrinology and metabolism.

[17]  I. Hay.  Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma , 2006, Journal of surgical oncology.

[18]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[19]  Z. Baloch,et al.  Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Bone Metastases , 2000, Modern Pathology.

[20]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.

[21]  S. Sontag.  Illness as Metaphor , 1978 .

[22]  Shinichiro,et al.  Carcinoma , 1906, The Hospital.